ASCEND BY NTHRYS
Research Abroad Products

Pharmacology Project Topics

Browse all focused areas across all project categories under this field.

Showing 169–180 of 210 project topics
Parathyroid Hormone Analog Rational Design and Modeling Suite
A computational platform for designing PTH receptor-selective analogs with optimized bone anabolic activity and minimal calcemic effects using structure-activity relationship mapping. This enables pharmaceutical companies to develop osteoporosis therapeutics with superior clinical efficacy, supporting premium market positioning and orphan drug opportunities.
Endocrine Pharmacology Drug Design Platforms Click to view more details →
Endocrine Polypharmacology Database and Drug Interaction Prediction
A comprehensive SaaS platform integrating endocrine receptor interaction data with machine learning algorithms to predict multi-target effects and hormone-drug interactions across therapeutic classes. This generates recurring revenue through subscription licensing while reducing clinical trial risk and supporting safer polypharmacy regimen development in aging populations.
Endocrine Pharmacology Drug Design Platforms Click to view more details →
AI-Powered GI Drug Candidate Screening Platform
A machine learning platform that rapidly identifies and validates promising gastrointestinal drug candidates by analyzing molecular structures, pharmacokinetics, and safety profiles against proprietary databases. This accelerates R&D timelines by 40-60%, reducing preclinical costs and enabling faster market entry for pharmaceutical companies.
Gastrointestinal Pharmacology Drug Discovery Click to view more details →
Microbiome-Targeted Therapeutic Discovery Software Suite
A computational platform designed to discover and optimize drugs that selectively modulate gut microbiota for treating IBS, IBD, and related disorders using real-time microbiome analysis data. Captures high-value licensing deals and partnership revenues from major pharma seeking microbiome-based therapeutics.
Gastrointestinal Pharmacology Drug Discovery Click to view more details →
Real-Time GI Drug Metabolism Predictive Analytics Engine
An advanced SaaS tool that predicts hepatic and intestinal metabolism, bioavailability, and drug-drug interactions for GI therapeutics using proprietary algorithms and in vitro data integration. Reduces failed clinical trials by 30% and generates recurring subscription revenue from biotech and pharma clients.
Gastrointestinal Pharmacology Drug Discovery Click to view more details →
Precision Motility Disorder Drug Development Platform
A specialized discovery platform targeting gastroparesis, IBS-C, and dysmotility through phenotype-driven screening and patient-stratification biomarkers. Opens unmet market opportunities worth $2B+ annually and enables targeted drug development with higher clinical success rates.
Gastrointestinal Pharmacology Drug Discovery Click to view more details →
Intestinal Barrier Function Optimization Technology Stack
A comprehensive SaaS solution combining in vitro intestinal models, permeability assays, and tight junction protein analysis to optimize oral bioavailability and GI safety. Delivers premium value to drug developers seeking to improve formulations and reduce adverse event liability.
Gastrointestinal Pharmacology Drug Discovery Click to view more details →
Smart GI Adverse Event Prediction and Risk Stratification Tool
An AI-enabled platform that predicts gastrointestinal toxicity, constipation, diarrhea, and ulceration risk during preclinical and clinical development using multi-modal biomarkers. Reduces post-market withdrawals and liability costs while enabling pharma to optimize dosing regimens and patient populations.
Gastrointestinal Pharmacology Drug Discovery Click to view more details →
Enzyme Inhibition and Transporter Interaction Modeling Service
A specialized consulting and software service that characterizes CYP450, UGTA, and transporter interactions for drugs targeting GI disorders, preventing costly clinical failures. Generates recurring consulting fees and software licensing revenue from mid-sized and large pharma entities.
Gastrointestinal Pharmacology Drug Discovery Click to view more details →
Inflammatory Bowel Disease Target Discovery Platform
A dedicated drug discovery platform leveraging patient-derived iPSCs, organoid systems, and immune profiling to identify novel IBD and ulcerative colitis targets. Captures partnership licensing deals worth $10M-50M+ from major immunology-focused biopharmaceutical companies.
Gastrointestinal Pharmacology Drug Discovery Click to view more details →
Oral Absorption Enhancement and Formulation Analytics Suite
A cloud-based platform that simulates GI conditions, predicts drug solubility and permeability, and recommends formulation strategies for maximizing bioavailability of GI therapeutics. Provides measurable cost savings in formulation development and enables faster regulatory approvals.
Gastrointestinal Pharmacology Drug Discovery Click to view more details →
Competitive Market Intelligence and Patent Landscape Analysis Tool
A commercial intelligence platform providing real-time competitive tracking, clinical trial monitoring, and patent landscape analysis specific to GI pharmacology drug development. Enables strategic positioning and licensing opportunities, generating B2B SaaS subscription revenue from biotech and pharma R&D teams.
Gastrointestinal Pharmacology Drug Discovery Click to view more details →